Autor/in Barosi, G 1 Besses, C 1 Birgegard, G 1 Cervantes, F 1 Finazzi, G 1 Gisslinger, H Griesshammer, M 1 Harrison, C 1 Hehlmann, R 1 Hermouet, S 1 Tefferi, A 1 alle zeigenListe einklappen
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) Barosi, G Tefferi, A Besses, C Birgegard, G Cervantes, F Finazzi, G Gisslinger, H 2014 - Forschungsinformationssystem des UKE
